Atrás
Rango del Día
$19.91
$21.17
Rango de 52 Semanas
$5.15
$27.65
Volumen
1,181,672
Promedio 50D / 200D
$22.70
/
$15.69
Cierre Anterior
$20.75
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -8.4 | 0.3 |
| P/B | 2.8 | 2.9 |
| ROE % | -52.1 | 3.7 |
| Net Margin % | -3060.0 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$36.83
+82.2%
Low: $32.00
High: $40.00
EPS Futuro
-$2.41
Ingresos Est.
4.4 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.36
-$0.14 – $3.69
|
620 M | 6 |
| FY2029 |
-$0.06
-$0.16 – $0.01
|
400 M | 6 |
| FY2028 |
-$1.18
-$2.86 – -$0.48
|
240 M | 8 |
Puntos Clave
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -200.60M
PEG of 0.17 suggests growth is underpriced
Capital intensive — 139.53% of revenue goes to capex
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)-23.23%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-52.09%
ROIC-25.16%
Net Margin-3059.99%
Op. Margin-3084.76%
Seguridad
Debt / Equity
0.01
Current Ratio14.69
Interest Coverage0.00
Valoración
P/E Ratio
-8.36
P/B Ratio2.80
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -23.23% | Revenue Growth (3Y) | -29.63% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 6.94M | Net Income (TTM) | -212.39M |
| ROE | -52.09% | ROA | -31.09% |
| Gross Margin | 57.43% | Operating Margin | -3084.76% |
| Net Margin | -3059.99% | Free Cash Flow (TTM) | -200.60M |
| ROIC | -25.16% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 14.69 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -8.36 | P/B Ratio | 2.80 |
| P/S Ratio | 255.82 | PEG Ratio | 0.17 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.78B | Enterprise Value | 1.13B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.94M | 9.04M | 14.02M | 0.0 | 0.0 |
| Net Income | -212.39M | -292.96M | -106.81M | -36.90M | -24.71M |
| EPS (Diluted) | -2.43 | -5.00 | -5.38 | -3.09 | -2.14 |
| Gross Profit | 3.99M | 9.04M | 14.02M | 0.0 | 0.0 |
| Operating Income | -214.11M | -305.80M | -109.53M | -36.90M | -25.20M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 683.19M | 240.24M | 148.54M | 24.05M | 57.93M |
| Total Liabilities | 48.85M | 59.08M | 28.66M | 7.39M | 9.74M |
| Shareholders' Equity | 634.34M | 181.17M | 119.88M | 16.65M | 48.19M |
| Total Debt | 3.86M | 4.83M | 1.65M | 291,000.0 | 317,000.0 |
| Cash & Equivalents | 653.48M | 143.35M | 98.68M | 20.32M | 49.23M |
| Current Assets | 660.78M | 221.34M | 144.70M | 22.65M | 56.64M |
| Current Liabilities | 44.99M | 54.31M | 21.83M | 7.33M | 9.73M |